Clinical Trial Update: Feasibility of Cannabidiol for the Treatment of Long COVID [Phase 2]

View source ↗

Summary

Phase 2 feasibility study assessing cannabidiol for the treatment of Long COVID has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Bod Australia | Conditions: Long COVID | Phase 2 | Status: COMPLETED